Market: NASD |
Currency: USD
Address: 21925 W. Field Parkway
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
📈 Eton Pharmaceuticals, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$30.00
-
Upside/Downside from Analyst Target:
73.41%
-
Broker Call:
6
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
25-50%
-
Net Income Growth Range (1Y):
25-50%
-
Revenue Growth Range (1Y):
50-100%
-
Upcoming Earnings Date:
2025-11-12
-
EPS Estimate:
0.16
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for Eton Pharmaceuticals, Inc.
| Date | Reported EPS |
|---|
| 2025-11-11 (estimated upcoming) | - |
| 2025-08-07 | 0.03 |
| 2025-05-13 | -0.06 |
| 2025-03-18 | -0.03 |
| 2024-11-12 | 0.02 |
| 2024-08-08 | -0.12 |
| 2024-05-09 | -0.03 |
| 2024-03-14 | -0.09 |
| 2023-11-09 | -0.02 |
| 2023-08-10 | 0.18 |
| 2023-05-11 | -0.1 |
| 2023-03-16 | 0.04 |
| 2022-11-10 | -0.12 |
| 2022-08-11 | -0.06 |
| 2022-05-12 | -0.21 |
| 2022-03-16 | 0.04 |
| 2021-11-15 | -0.24 |
| 2021-08-16 | -0.1 |
| 2021-05-13 | 0.19 |
| 2021-03-16 | -0.29 |
| 2020-11-12 | -0.31 |
| 2020-08-12 | -0.23 |
| 2020-05-14 | -0.5 |
| 2020-03-05 | -0.15 |
| 2019-11-14 | -0.28 |
📰 Related News & Research
No related articles found for "eton pharmaceuticals".
